NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: alzheimer's disease

12/19/2018

Guardian jumps to conclusions about an Alzheimer’s study that hasn’t even begun

11/28/2018

USA Today provides rosy speculation about an Alzheimer’s vaccine not yet tested in humans

11/9/2018

Fox News regurgitates a hot mess from the UK Sun

7/25/2018

HealthDay provides needed details on side effects of THC-based drug studied for Alzheimer’s agitation

4/11/2018

Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients

2/19/2018

ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s

2/1/2018

An Alzheimer’s study that included just 3 people: Does that warrant consumer news coverage?

11/8/2017

Preliminary Alzheimer’s study involving plasma infusions–was this really newsworthy?

8/1/2017

Do PET scans improve dementia diagnosis? LA Times story overlooks harms of screening

5/2/2017

STAT’s cautious story provides interesting insights into challenges of Alzheimer’s research